The expression of monocarboxylate transporters (MCTs) is linked to pathophysiological changes in diseases, including cancer, such that MCTs could potentially serve as diagnostic markers or therapeutic targets. We recently developed [18F]FACH as a radiotracer for non-invasive molecular imaging of MCTs by positron emission tomography (PET). The aim of this study was to evaluate further the specificity, metabolic stability, and pharmacokinetics of [18F]FACH in healthy mice and piglets. We measured the [18F]FACH plasma protein binding fractions in mice and piglets and the specific binding in cryosections of murine kidney and lung. The biodistribution of [18F]FACH was evaluated by tissue sampling ex vivo and by dynamic PET/MRI in vivo, with and without pre-treatment by the MCT inhibitor α-CCA-Na or the reference compound, FACH-Na. Additionally, we performed compartmental modelling of the PET signal in kidney cortex and liver. Saturation binding studies in kidney cortex cryosections indicated a KD of 118 ± 12 nM and Bmax of 6.0 pmol/mg wet weight. The specificity of [18F]FACH uptake in the kidney cortex was confirmed in vivo by reductions in AUC0-60min after pre-treatment with α-CCA-Na in mice (-47%) and in piglets (-66%). [18F]FACH was metabolically stable in mouse, but polar radio-metabolites were present in plasma and tissues of piglets. The [18F]FACH binding potential (BPND) in the kidney cortex was approximately 1.3 in mice. The MCT1 specificity of [18F]FACH uptake was confirmed by displacement studies in 4T1 cells. [18F]FACH has suitable properties for the detection of the MCTs in kidney, and thus has potential as a molecular imaging tool for MCT-related pathologies, which should next be assessed in relevant disease models.

O objetivo desse trabalho foi avaliar a expressão de genes envolvidos no transporte de monocarboxilatos (Mct1, Mct2, Mct3 e Mct4) e de genes específicos da oogênese (Bmp15, Gdf9 e Has2) em complexos cumulus-oócito (CCOs) selecionados pelo teste BCB. Após seleção morfológica com base no grau de compactação das células do cumulus (CCs) e no grau de homogeneidade do citoplasma, os CCOs foram corados com 26 μM BCB (azul cresil brilhante) por 90 min e divididos em dois grupos: BCB+, que apresentavam o ooplasma corado de azul, e BCB-, com ooplasma não corado. Foram utilizados dois grupos controles não expostos ao BCB: o grupo holding foi submetido às mesmas condições que os grupos corados e o outro grupo controle foi diretamente submetido à maturação in vitro (MIV), após a seleção morfológica dos CCOs. A expressão gênica relativa foi determinada por RT-PCR em CCOs coletados antes e ao final da maturação. A expressão também foi avaliada, separadamente, em oócitos desnudos (ODs) e células do cumulus (CCs) antes e após a maturação. A análise dos transcritos demonstrou que houve aumento significativo (p < 0,05) na expressão relativa de Gdf9 e Bmp15 nos grupos BCB+, BCB- e holding antes da MIV, enquanto Has2 teve aumento significativo (p < 0,01) após a MIV apenas no grupo controle. Os outros genes analisados (Mct1, Mct2 e Mct4) mantiveram-se estáveis durante a maturação. O aumento na abundância relativa de alguns transcritos durante a MIV pode ser atribuído as condições de incubações durante o teste BCB. Nossos resultados demonstraram, pela primeira vez, a expressão de Mct1, 2 e 4 em CCOs bovinos. Enquanto o mRNA de Mct1 e Mct4 estava presente em ODs e em CC, o Mct2 foi detectado somente em CCs. Não detectamos a expressão de transcritos de Mct3 em CCOs. As diferenças na expressão dessas três isoformas sugerem um papel único para esses transportadores durante a maturação. / The aim of this study was to determine the relative expression of genes involved in transport of monocarboxylates (Mct1, Mct2, Mct3 e Mct4) and oogenesis specific genes (Bmp15, Gdf9 and Has2) in immature and mature bovine cumulus-oocyte complexes (COC) after selection by BCB. Immature COCs underwent morphological selection and were stained with 26 mM BCB for 90 min. Based on ooplasm staining, oocytes were distributed in two groups BCB+ (blue color) and BCB- (non-stained). The holding control group was exposed to the same incubation conditions as stained COCs, but without BCB. Control group was submitted to in vitro maturation (IVM) immediately after morphological selection. mRNA expression was investigated by RT-PCR in COCs before and after IVM. No relationship was observed in the relative expression of Has2, Gdf9, Bmp15 or Mct1, 2 and 4 transcripts between BCB- and BCB+ COCs. Transcripts analysis showed that Gdf9 and Bmp15 in BCB+, BCB- and holding groups were upregulated (p < 0.05) before IVM, while Has2 was up-regulated (p < 0.01) after IVM in the control group. Others genes remained stable during maturation (Mct1, 2 and 4). The increase in relative abundance of some transcripts during IVM may be attributed to incubation conditions during the BCB test. Our results showed, for the first time, Mct1, 2 and 4 expression in bovine COCs. Mct1 and Mct4 transcripts were present in denuded oocytes and cumulus cell, while Mct2 was detected only in cumulus cells. These differences between the three isoforms in localization suggest unique roles for each in monocarboxylate transport during maturation.

Although it was once thought that neurons solely rely on glucose as a substrate for cellular energy production, it is now known that small monocarboxylate molecules, like pyruvate, lactate, and ketone bodies, are also utilized. Monocarboxylates are transported across plasma membranes via facilitated diffusion using a family of transport proteins known as monocarboxylate transporters (MCTs). Four MCTs (MCT1, MCT2, MCT3, and MCT4) are expressed within neural tissues. Expression of the MCTs has been tied to co-expression of a cell adhesion molecule belonging to the Basigin subset of the immunoglobulin superfamily (IgSF). Basigin gene products are known to interact with MCT1 and MCT4 in the mammalian neural retina and this association is essential to support the cellular energy needs of photoreceptors. A previous study indicated that Basigin gene products use hydrophobic amino acids within specific regions of the transmembrane domain to interact with MCT1. In the present study, it is hypothesized that the same amino acids within the transmembrane domain are used to interact with MCT4, but that no association exists with MCT2, which typically interacts with a different member of the IgSF subset. Therefore, the purpose of the present study was to assess the association between Basigin gene products and MCT4, and with MCT2. Recombinant proteins corresponding to the transmembrane domain of Basigin gene products were used in in vitro binding assays with endogenous MCT2 and MCT4 from mouse brain protein lysates. Contrary to the hypothesis, it was determined that the transmembrane domain of Basigin gene products binds to both MCT2 and MCT4 in vitro. Different amino acids within the transmembrane domain of Basigin gene products are used for each association and the pattern is different from that used in the association with MCT1. The data suggest that Basigin plays multiple roles in the nervous system.

Les tumeurs solides sont souvent confrontées à un environnement déficient en oxygène, dit hypoxique. Hypoxia-Inducible Factor 1 (HIF1) est le facteur de transcription clé de l’adaptation cellulaire à l’hypoxie, régulant de nombreux gènes impliqués dans l’angiogenèse, le métabolisme cellulaire ou la régulation du pH. Ma thèse s’articule en trois axes autour de HIF1 et de la reprogrammation métabolique hypoxique. J’ai d’abord étudié Factor-Inhibiting HIF1 (FIH), l’un des deux senseurs d’oxygène régulant HIF1. Nous avons montré que FIH est essentiel dans le développement tumoral en inhibant à la fois l’activité transcriptionnelle de HIF1 et la voie p53-p21. J’ai ensuite étudié le « shift » du métabolisme cellulaire vers la glycolyse induit par HIF1, générant une addiction pour le glucose. Nos travaux ont montré que paradoxalement, les cellules hypoxiques synthétisent du glycogène via HIF1 constituant ainsi une réserve de glucose intracellulaire. Le glycogène confère alors une résistance accrue des cellules tumorales suite à une carence en glucose. Enfin, j’ai pu montrer que l’AMPK, « gardien de la balance énergétique », n’est pas nécessaire au maintien d’un niveau viable d’ATP suite à l’inhibition de la glycolyse, via le blocage de l’export de lactate, mais exerce, un effet protecteur en absence de glucose. Cependant, l’inhibition conjointe du transporteur de lactate, MCT4, et de l’AMPK réduit fortement le développement tumoral dans un modèle de xénogreffes chez la souris, suggérant un rôle crucial de ces deux acteurs dans ce contexte. L’ensemble de ces travaux a permis d’identifier plusieurs cibles potentielles impliquées dans la plasticité métabolique en hypoxie. / Cells of solid tumors are often exposed to an environment deficient in oxygen, i.e. hypoxic. The Hypoxia-Inducible Factor-1 (HIF-1) is the major transcription factor involved in cellular adaptation to hypoxia. HIF-1 regulates a wide array of genes involved in angiogenesis, cellular metabolism or pH regulation. My thesis is organized into three axes around HIF-1 and metabolic reprogramming in hypoxia. I first studied Factor-Inhibiting HIF-1 (FIH), one of two oxygen sensors regulating HIF-1. We showed that FIH is essential for tumor development through inhibition of the HIF-1 transcriptional activity as well as through the suppression of the p53-p21 axis. I then studied the HIF-1-induced « shift » in cellular metabolism toward glycolysis, which generates a type of “glucose addiction”. We showed that paradoxically, tumor cells store glycogen in hypoxia through a HIF-1 dependant mechanism. Glycogen served as a reservoir of intracellular glucose, which allows hypoxic cells to survive periods of glucose starvation. Finally, I studied AMPK «the guardian of energy », and showed that surprisingly, this kinase is not necessary in maintaining a viable level of ATP when glycolysis is inhibited (by blockade of lactate export). However, as expected, AMPK protected cells during glucose starvation. Moreover, combined inhibition of the lactate transporter MCT4 and of AMPK reduced dramatically tumor development in a xenograft model, suggesting a crucial role for these two actors in the context of growth of tumor cells in a hostile environment. Taken together these results identified several potential drug targets involved in the metabolic plasticity of hypoxic cells.

O objetivo desse trabalho foi avaliar a expressão de genes envolvidos no transporte de monocarboxilatos (Mct1, Mct2, Mct3 e Mct4) e de genes específicos da oogênese (Bmp15, Gdf9 e Has2) em complexos cumulus-oócito (CCOs) selecionados pelo teste BCB. Após seleção morfológica com base no grau de compactação das células do cumulus (CCs) e no grau de homogeneidade do citoplasma, os CCOs foram corados com 26 μM BCB (azul cresil brilhante) por 90 min e divididos em dois grupos: BCB+, que apresentavam o ooplasma corado de azul, e BCB-, com ooplasma não corado. Foram utilizados dois grupos controles não expostos ao BCB: o grupo holding foi submetido às mesmas condições que os grupos corados e o outro grupo controle foi diretamente submetido à maturação in vitro (MIV), após a seleção morfológica dos CCOs. A expressão gênica relativa foi determinada por RT-PCR em CCOs coletados antes e ao final da maturação. A expressão também foi avaliada, separadamente, em oócitos desnudos (ODs) e células do cumulus (CCs) antes e após a maturação. A análise dos transcritos demonstrou que houve aumento significativo (p < 0,05) na expressão relativa de Gdf9 e Bmp15 nos grupos BCB+, BCB- e holding antes da MIV, enquanto Has2 teve aumento significativo (p < 0,01) após a MIV apenas no grupo controle. Os outros genes analisados (Mct1, Mct2 e Mct4) mantiveram-se estáveis durante a maturação. O aumento na abundância relativa de alguns transcritos durante a MIV pode ser atribuído as condições de incubações durante o teste BCB. Nossos resultados demonstraram, pela primeira vez, a expressão de Mct1, 2 e 4 em CCOs bovinos. Enquanto o mRNA de Mct1 e Mct4 estava presente em ODs e em CC, o Mct2 foi detectado somente em CCs. Não detectamos a expressão de transcritos de Mct3 em CCOs. As diferenças na expressão dessas três isoformas sugerem um papel único para esses transportadores durante a maturação. / The aim of this study was to determine the relative expression of genes involved in transport of monocarboxylates (Mct1, Mct2, Mct3 e Mct4) and oogenesis specific genes (Bmp15, Gdf9 and Has2) in immature and mature bovine cumulus-oocyte complexes (COC) after selection by BCB. Immature COCs underwent morphological selection and were stained with 26 mM BCB for 90 min. Based on ooplasm staining, oocytes were distributed in two groups BCB+ (blue color) and BCB- (non-stained). The holding control group was exposed to the same incubation conditions as stained COCs, but without BCB. Control group was submitted to in vitro maturation (IVM) immediately after morphological selection. mRNA expression was investigated by RT-PCR in COCs before and after IVM. No relationship was observed in the relative expression of Has2, Gdf9, Bmp15 or Mct1, 2 and 4 transcripts between BCB- and BCB+ COCs. Transcripts analysis showed that Gdf9 and Bmp15 in BCB+, BCB- and holding groups were upregulated (p < 0.05) before IVM, while Has2 was up-regulated (p < 0.01) after IVM in the control group. Others genes remained stable during maturation (Mct1, 2 and 4). The increase in relative abundance of some transcripts during IVM may be attributed to incubation conditions during the BCB test. Our results showed, for the first time, Mct1, 2 and 4 expression in bovine COCs. Mct1 and Mct4 transcripts were present in denuded oocytes and cumulus cell, while Mct2 was detected only in cumulus cells. These differences between the three isoforms in localization suggest unique roles for each in monocarboxylate transport during maturation.

O objetivo desse trabalho foi avaliar a expressão de genes envolvidos no transporte de monocarboxilatos (Mct1, Mct2, Mct3 e Mct4) e de genes específicos da oogênese (Bmp15, Gdf9 e Has2) em complexos cumulus-oócito (CCOs) selecionados pelo teste BCB. Após seleção morfológica com base no grau de compactação das células do cumulus (CCs) e no grau de homogeneidade do citoplasma, os CCOs foram corados com 26 μM BCB (azul cresil brilhante) por 90 min e divididos em dois grupos: BCB+, que apresentavam o ooplasma corado de azul, e BCB-, com ooplasma não corado. Foram utilizados dois grupos controles não expostos ao BCB: o grupo holding foi submetido às mesmas condições que os grupos corados e o outro grupo controle foi diretamente submetido à maturação in vitro (MIV), após a seleção morfológica dos CCOs. A expressão gênica relativa foi determinada por RT-PCR em CCOs coletados antes e ao final da maturação. A expressão também foi avaliada, separadamente, em oócitos desnudos (ODs) e células do cumulus (CCs) antes e após a maturação. A análise dos transcritos demonstrou que houve aumento significativo (p < 0,05) na expressão relativa de Gdf9 e Bmp15 nos grupos BCB+, BCB- e holding antes da MIV, enquanto Has2 teve aumento significativo (p < 0,01) após a MIV apenas no grupo controle. Os outros genes analisados (Mct1, Mct2 e Mct4) mantiveram-se estáveis durante a maturação. O aumento na abundância relativa de alguns transcritos durante a MIV pode ser atribuído as condições de incubações durante o teste BCB. Nossos resultados demonstraram, pela primeira vez, a expressão de Mct1, 2 e 4 em CCOs bovinos. Enquanto o mRNA de Mct1 e Mct4 estava presente em ODs e em CC, o Mct2 foi detectado somente em CCs. Não detectamos a expressão de transcritos de Mct3 em CCOs. As diferenças na expressão dessas três isoformas sugerem um papel único para esses transportadores durante a maturação. / The aim of this study was to determine the relative expression of genes involved in transport of monocarboxylates (Mct1, Mct2, Mct3 e Mct4) and oogenesis specific genes (Bmp15, Gdf9 and Has2) in immature and mature bovine cumulus-oocyte complexes (COC) after selection by BCB. Immature COCs underwent morphological selection and were stained with 26 mM BCB for 90 min. Based on ooplasm staining, oocytes were distributed in two groups BCB+ (blue color) and BCB- (non-stained). The holding control group was exposed to the same incubation conditions as stained COCs, but without BCB. Control group was submitted to in vitro maturation (IVM) immediately after morphological selection. mRNA expression was investigated by RT-PCR in COCs before and after IVM. No relationship was observed in the relative expression of Has2, Gdf9, Bmp15 or Mct1, 2 and 4 transcripts between BCB- and BCB+ COCs. Transcripts analysis showed that Gdf9 and Bmp15 in BCB+, BCB- and holding groups were upregulated (p < 0.05) before IVM, while Has2 was up-regulated (p < 0.01) after IVM in the control group. Others genes remained stable during maturation (Mct1, 2 and 4). The increase in relative abundance of some transcripts during IVM may be attributed to incubation conditions during the BCB test. Our results showed, for the first time, Mct1, 2 and 4 expression in bovine COCs. Mct1 and Mct4 transcripts were present in denuded oocytes and cumulus cell, while Mct2 was detected only in cumulus cells. These differences between the three isoforms in localization suggest unique roles for each in monocarboxylate transport during maturation.

No description available.

Der Monocarboxylattransporter 8 (Mct8) ist ein spezifischer Schilddrüsenhormon (SDH)-Transporter. MCT8-Mutationen führen zu einer psychomotorischen Retardierung in Kombination mit abnormalen SDH-Serumkonzentrationen. Das konstitutiv Mct8-defiziente Mausmodell repliziert den endokrinologischen, jedoch nicht den humanen neurologischen Phänotyp. Um die Hypothese eines stark beeinträchtigten T3-Transportes speziell in Neuronen als Ursache zu untersuchen, wurde das Neuron-spezifische Mct8-defiziente Mausmodell (CamK-Cre;Mct8fl/fl) generiert. Neben einer funktionalen, Mct8-exprimierenden Blut-Hirn-Schranke liegt eine funktionale Hypophysen-Hypothalamus-Schilddrüsen Achse vor. NMR-Analysen des zerebralen Energiestoffwechsels von CamK-Cre;Mct8fl/fl-Mäusen zeigen nach [1-13C] Glukoseinfusion verringerte Laktatintensitäten sowie eine reduzierte Laktatdehydrogenase-Aktivität. Zudem sind Astrozyten-spezifische Transporter und Enzyme des Neurotransmitterstoffwechsels und deren Biosynthese in ihrer Genexpression reduziert. Somit führt der neuronale Mct8-Verlust zu einem verlangsamten zerebralen Metabolismus sowie einer reduzierten neuronalen Aktivität. Die Rolle von Mct8 im Energiestoffwechsel wurde außerdem in primären Mct8-defizienten Astrozyten- und Neuronkulturen mittels Seahorse Flux Analyzer untersucht. In Mct8-defizienten Neuronen kommt es zu einer verringerten SDH-Aufnahme, was in einer verringerten Expression von OXPHOS-relevanten Proteinen sowie in einer verringerten Sauerstoffverbrauchsrate resultiert. Somit stützen die in vitro Daten die des CamK-Cre;Mct8fl/fl-Mausmodelles bezüglich einer reduzierten neuronalen Aktivität sowie eines verlangsamten zerebralen Stoffwechsels. Zusammenfassend zeigen die Ergebnisse, dass grundlegende Mechanismen des zerebralen Stoffwechsels bei neuronaler Mct8-Defizienz beeinträchtigt sind und die Rolle von Mct8 mit Hilfe weiterer konditioneller Mausmodelle (Astrozyten-spezifisch) und primären Ko-Kulturmodellen untersucht werden muss. / The monocarboxylate transporter 8 (Mct8) is the most specific thyroid hormone (TH) transporter. Mutations lead to a severe form of psychomotor retardation in combination with abnormal TH concentrations in sera. The global Mct8-deficient mouse model was intensively studied and it replicates the endocrine, but not the human neurological phenotype. To test the hypothesis, that a disturbed uptake of T3 especially into neurons is responsible for the phenotype, we generated a neuron-specific Mct8-deficient mouse model (CamK-Cre;Mct8fl/fl). CamK-Cre;Mct8fl/fl mice exhibit a functional Mct8-expressing blood-brain-barrier and a functional hypothalamus pituitary thyroid axis. NMR analyses of the cerebral energy metabolism of CamK-Cre;Mct8fl/fl mice after [1-13C] glucose injection revealed less enrichment of lactate and a reduced lactate dehydrogenase activity. Moreover, especially astrocyte-specific expressed transporter and enzymes of neurotransmitter metabolism and their biosynthesis are significantly reduced in comparison to control mice. These results point to a decelerated cerebral metabolism as well as a reduced neuronal activity caused by the neuronal loss of Mct8. In addition, we studied the impact of Mct8 on the energy metabolism in primary wildtype and Mct8-deficient astrocyte and neuron cultures by use of the Seahorse Flux Analyzer. Mct8-deficient neurons show a reduced uptake of TH, which results in a reduced expression of OXPHOS relevant proteins as well as a reduced oxygen consumption rate. Therefore, the in vitro raised data provide the observed changes of the CamK-Cre;Mct8fl/fl mice regarding a reduced synaptic activity as well as a reduced cerebral metabolism. Taken together, the data clearly shows that basic mechanisms of the cerebral metabolism are hampered in neuronal Mct8 deficiency. The role of Mct8 in this context needs further analyses with the help of conditional mouse models (astrocyte-specific) and primary co-culture models.

The current understanding of lactate metabolism in fish is based almost entirely on interpretation of concentration measurements that cannot be used to infer changes in flux. Moreover, the transporters regulating these fluxes have never been characterized in rainbow trout. My goals were: (1) to quantify lactate fluxes in rainbow trout under normoxic resting conditions, during acute hypoxia, and exercise by continuous infusion of [U-14C] lactate; (2) to determine lactate uptake capacity of trout tissues by infusing exogenous lactate in fish rest and during graded exercise, and (3) to clone monocarboxylate transporters (MCTs) and determine the effects of exhausting exercise on their expression. Such information could prove important to understand the mechanisms underlying the classic “lactate retention” seen in trout white muscle after intense exercise. In normoxic resting fish, the rates of appearance (Ra) and disappearance (Rd) of lactate were always matched (~18 to 13 µmol kg-1 min-1), thereby maintaining a low baseline blood lactate concentration (~0.8 mM). In hypoxic fish, Ra lactate increased from baseline to 36.5 µmol kg-1 min-1, and was accompanied by an unexpected 52% increase in Rd reaching 30.3 µmol kg-1 min-1, accounting for a rise in blood lactate to 8.9 mM. In exercising fish, lactate flux was stimulated > 2.4 body lengths per second (BL s-1). As the fish reached critical swimming speed (Ucrit), Ra lactate was more stimulated (+67% to 40.4 μmol kg-1 min-1) than Rd (+41% to 34.7 μmol kg-1 min-1), causing an increase in blood lactate to 5.1mM. Fish infused with exogenous lactate stimulated Rd lactate by 300% (14 to 56 μmol kg-1 min-1) during graded exercise, whereas the Rd in resting fish increased by only 90% (21 to 40 µmol kg-1 min-1). Four MCT isoforms were partially cloned and characterized in rainbow trout: MCT1b was the most abundant in heart, and red muscle, but poorly expressed in gill and brain where MCT1a and MCT2 were prevalent. MCT4 was more expressed in the heart. Transcript levels of MCT2 (+260%; brain), MCT1a (+90%; heart) and MCT1b (+50%; heart) were stimulated by exhausting exercise. This study shows that: (i) the increase in Rd lactate plays a strategic role in reducing the lactate load imposed on the circulation. Without this response, blood lactate accumulation would double; (ii) a high capacity for lactate disposal in rainbow trout tissues is elicited by the increased blood-to-tissue lactate gradient when extra lactate is administered; and (iii) rainbow trout may be unable to release large lactate loads rapidly from white muscle after exhausting exercise (lactate retention) because they poorly express MCT4 in white muscle and fail to upregulate its expression during exercise.

Einleitung: Kurzkettige Fettsäuren (SCFA) stellen das hauptsächliche Energiesubstrat für Wiederkäuer dar. In Anbetracht des - bedingt durch höhere Milch-, Mast und Reproduktionsleistung - steigenden Energiebedarfs von Hauswiederkäuern wie Milchkuh und Mastbulle ist es von zentraler Bedeutung, die Mechanismen zur Resorption dieser Energielieferanten bzw. Ansatzpunkte für die Beeinflussung dieser Transportprozesse genau zu kennen. Dieses Wissen kann möglicherweise dabei helfen, zukünftig die Energieaufnahme der Tiere zu unterstützen bzw. sogar effizienter zu gestalten. Ziele der Untersuchungen: Deshalb war es Ziel der vorliegenden Arbeit, die Mechanismen zur Resorption von SCFA zu charakterisieren, wobei der Schwerpunkt auf den Transport aus den Pansenepithelzellen ins Blut gelegt wurde, da hierzu im Gegensatz zu ihrer Aufnahme aus dem Pansenlumen in die Epithelzellen noch sehr wenig bekannt war. In einem zweiten Schritt sollte untersucht werden, inwiefern die nachgewiesenen Mechanismen einer Regulation unterliegen und über welche Signalwege diese vermittelt werden könnte. Materialien und Methoden: Zur Charakterisierung der beteiligten Resorptionsmechanismen wurden Epithelstücke aus dem ventralen Pansensack von Schafen in Ussing-Kammern eingespannt und mit Hilfe radioaktiv markierten Azetats, Butyrats und L-Laktats der Transport dieser Substrate unter verschiedenen Bedingungen sowie verschiedenen Hemmstoffeinflüssen untersucht. Zur Charakterisierung regulativer Einflüsse wurden die Epithelstücke über sechs bzw. 24 Stunden mit Butyrat inkubiert und anschließend RNA bzw. Totalprotein extrahiert. Hiermit konnten Veränderungen in mRNA- und Proteinexpression mittels quantitativer Echtzeit-PCR bzw. Western Blot nachgewiesen werden. Ergebnisse: Die Untersuchungen der vorliegenden Arbeit konnten zeigen, dass der Transport von SCFA über die basolaterale Membran des Pansenepithels hauptsächlich proteinvermittelt erfolgt. Eine signifikante Beteiligung lipophiler Diffusion, d.h. ein passiver Transport, kann weitgehend ausgeschlossen werden. Der aktive Transport wies eine bikarbonatabhängige und eine bikarbonatunabhängige Komponente auf. Der Einsatz von Hemmstoffen verschiedener Transportproteine ergab deutliche Hinweise darauf, dass der Monocarboxylattransporter (MCT) 1 eine Rolle beim bikarbonatgekoppelten Transport von Azetat bzw. allgemein unmetabolisierten SCFA spielt. Diese Hinweise wurden untersetzt durch die Beobachtung, dass MCT 1, aber auch der apikal bzw. intrazellulär lokalisierte MCT 4 durch langfristige Inkubation des Epithels mit Butyrat sowohl auf mRNA- als auch auf Proteinebene signifikant erhöht exprimiert wurden, was als Anpassungsreaktion an eine Substratakkumulation interpretiert werden kann. Außerdem wurde auch die mRNA-Expression des Putativen Anionentransporters (PAT) 1 durch Inkubation mit Butyrat erhöht, was für eine Beteiligung auch dieses Transportproteins am SCFA-Transport über das Pansenepithel spricht. Allerdings ist im Gegensatz zu MCT 1 die Lokalisation des PAT 1 in der basolateralen Membran noch fraglich. Die Expressionssteigerung von Zielgenen des Nukleären Faktors ĸB und des Peroxisomenproliferator-aktivierten Rezeptors α sowie des Hypoxie-induzierbaren Faktors selbst deuten weiterhin darauf hin, dass die Steigerung der Transportkapazitäten von MCT 1 und 4 und auch PAT 1 über diese Signalwege vermittelt wird. Schlussfolgerungen: Zusammenfassend konnte in dieser Arbeit erstmals der Transport von SCFA über die basolaterale Membran des Pansenepithels näher charakterisiert werden, sodass es nun möglich ist, zusammen mit den bereits vorliegenden Befunden für die apikale Membran ein komplettes Modell dafür zu erstellen. Auch wurden Erkenntnisse zu regulativen Einflüssen auf diesen Transport gewonnen, die es zukünftig ermöglichen könnten, die Resorption der SCFA aus dem Pansen nutritiv oder eventuell pharmakologisch zu beeinflussen. / Introduction: The main energy source for ruminants are short chain fatty acids (SCFA). Considering the ever increasing energy requirements of cattle due to increasing milk yield and meat production, it is crucial to identify the mechanisms for the resorption of these energy sources as well as possibilities to influence these transport mechanisms. This knowledge could help support the animals’ energy uptake or even making it more efficient. Aim: Thus, the aim of the present study was to characterise mechanisms for the resorption of SCFA focusing on their transport from the epithelial cells into the blood. In particular, since – compared to the research findings on the uptake of SCFA from ruminal lumen into the cells – so far only very little was known regarding this side of the epithelium. In a second step, the study aimed to elucidate whether the mechanisms observed are subject to regulatory processes and which signalling pathways are involved. Materials and methods: To characterise the transport mechanisms involved, epithelial pieces from the ventral sac of ovine rumen were mounted in Ussing chambers. Using radioactively labelled acetate, butyrate and L-lactate, the transport of these substrates was investigated under different conditions and by applying different inhibitors for potential SCFA transport proteins. To characterise regulatory influences, epithelial pieces were incubated with butyrate for six and 24 hours, respectively. Subsequently, total RNA and protein were extracted to detect changes in mRNA and protein expression using quantitative real time PCR and western blot, respectively. Results: The present study could show that transport of SCFA across the basolateral membrane of rumen epithelium is mainly realised by protein-mediated mechanisms. A significant participation of lipophilic diffusion, i.e. a passive transport, can almost entirely be excluded. The active transport could be divided into a bicarbonate-dependent and a bicarbonate-independent part. The experiments with inhibitors of different transport proteins showed clear evidence of an involvement of monocarboxylate transporter (MCT) 1 in the bicarbonate-dependent transport of acetate and non-metabolised SCFA in general. This evidence was supported by the finding that the expression of MCT 1 but also of the apically and intracellularly localised MCT 4 was increased significantly on both mRNA- and protein-level after long-term incubation of the epithelium with butyrate. This can be interpreted as an adaptation to a substrate accumulation. Additionally, butyrate incubation led to an increased mRNA expression of putative anion transporter (PAT) 1, which makes an involvement of this transport protein in SCFA transport across ruminal epithelium likely as well. However, in contrast to MCT 1 the localisation of PAT 1 in the basolateral membrane is still questionable. The increased expression of target genes of nuclear factor ĸB and peroxisome-proliferator activated receptor α as well as of hypoxia inducible factor strongly point to an involvement of these pathways in the increased expression of MCT 1 and 4 as well as PAT 1. Conclusions: In summary, this study could characterise the transport of SCFA across the basolateral membrane of ruminal epithelium in detail for the first time. This enables us to draw a complete model of ruminal SCFA transport. Also, evidence for regulatory influence on this transport processes was found, perhaps making it possible to influence resorption of SCFA from rumen by nutritive or pharmacological means in the future.